3-iodobenzylguanidine has been researched along with Hepatocellular Carcinoma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guan, XQ; Liu, FQ; Su, Y; Wang, YL | 1 |
Cai, H; Huang, R; Ou, X; Wu, X; Zhao, Y; Zhong, X | 1 |
Deng, HF; Huang, R; Jia, ZY; Ou, XH; Qi, ZZ; Yang, XC; Yang, YY | 1 |
Bardiès, M; Buvat, I | 1 |
Akahane, M; Ijichi, H; Inoue, Y; Kitazawa, T; Obi, S; Ohtomo, K; Omata, M; Yoshikawa, K | 1 |
Buscombe, JR | 1 |
Altmann, A; Haberkorn, U; Kissel, M; Kübler, W; Mahmut, M; Peschke, P; Zitzmann, S | 1 |
Gritters, LS; Wahl, RL | 1 |
Endo, K; Fujita, T; Inoue, G; Koizumi, M; Konishi, J; Maki, A; Mori, K; Nakano, Y; Ohta, H; Ozawa, K | 1 |
2 review(s) available for 3-iodobenzylguanidine and Hepatocellular Carcinoma
Article | Year |
---|---|
Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
Topics: 3-Iodobenzylguanidine; Bone Marrow; Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Neuroendocrine Tumors; Nuclear Medicine; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Single photon emission computed tomography in cancer imaging.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Gallium Radioisotopes; Hemangioma; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lymphoma; Neoplasms; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon | 1993 |
7 other study(ies) available for 3-iodobenzylguanidine and Hepatocellular Carcinoma
Article | Year |
---|---|
The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells.
Topics: 3-Iodobenzylguanidine; ADP Ribose Transferases; Antigens, CD; Carcinoma, Hepatocellular; Cell Movement; Female; Fluorescent Antibody Technique; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Hep G2 Cells; Humans; Inhibitory Concentration 50; Integrin alpha Chains; Liver Neoplasms; Male; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Urokinase-Type Plasminogen Activator | 2014 |
Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Genetic Therapy; Hep G2 Cells; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Norepinephrine Plasma Membrane Transport Proteins; Radionuclide Imaging; Radiopharmaceuticals; Transfection; Vesicular Monoamine Transport Proteins | 2017 |
In vitro and in vivo studies of adenovirus-mediated human norepinephrine transporter gene transduction to hepatocellular carcinoma.
Topics: 3-Iodobenzylguanidine; Adenoviridae; Adrenal Gland Neoplasms; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Transfer Techniques; Genetic Vectors; HEK293 Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Norepinephrine Plasma Membrane Transport Proteins; Radiography; Radionuclide Imaging; Xenograft Model Antitumor Assays | 2011 |
False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma.
Topics: 3-Iodobenzylguanidine; Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; False Positive Reactions; Humans; Hypertension; Liver Neoplasms; Male; Neuroendocrine Tumors; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Interventional nuclear medicine in hepatocellular carcinoma and other tumours.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Carriers; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Microspheres; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Treatment Outcome; Yttrium Radioisotopes | 2002 |
Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Hepatocellular; Cloning, Molecular; Humans; Liver Neoplasms, Experimental; Male; Metabolic Clearance Rate; Neoplasm Transplantation; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rats; Recombinant Proteins; Reference Values; Symporters; Tissue Distribution; Transduction, Genetic; Tumor Cells, Cultured | 2003 |
Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Carcinoma; Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Multiple Endocrine Neoplasia; Neoplasms, Multiple Primary; Organometallic Compounds; Pheochromocytoma; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1988 |